Related Experiment Video

Updated: Jun 11, 2026

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique
07:34

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique

Published on: December 15, 2023

Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?

Jeannette N Stankowski1, Rishi Gupta

  • 1Neuroscience Graduate Program, Vanderbilt University, Nashville, Tennessee, USA.

Antioxidants & Redox Signaling
|July 15, 2010
PubMed

Insights

Developing neuroprotective agents for ischemic stroke has been challenging. Understanding molecular mechanisms and patient variability is key for future stroke treatment success.

Area of Science:

  • Neuroscience
  • Neurology
  • Biomedical Science

Background:

  • Clinical translation of neuroprotective agents for ischemic stroke has largely failed.
  • Current strategies focus on preserving the ischemic penumbra, but infarct core variability impacts prognosis.
  • Understanding this variability is crucial for patient selection and therapeutic development.

Purpose of the Study:

  • To review molecular pathways involved in ischemic stroke.
  • To place these pathways within the clinical context of stroke treatment.
  • To identify potential future therapeutic targets for ischemic stroke.

Main Methods:

  • Literature review of molecular mechanisms in neuronal injury during ischemic stroke.
  • Analysis of clinical context and patient variability in stroke outcomes.
  • Evaluation of current and evolving reperfusion therapies.

Main Results:

  • Neuroprotection trials have faced significant clinical translation challenges.
  • Infarct core size, not just penumbra, is a critical prognostic factor.
  • Reperfusion therapies show promise, but neuroprotective agents may enhance their efficacy.

Conclusions:

  • Future neuroprotection strategies must consider the clinical context and patient variability.
  • Targeting molecular pathways to prevent reperfusion injury may offer new therapeutic avenues.
  • Integrating bench research with clinical realities is essential for advancing ischemic stroke treatment.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.